Predictive impact of electrolyte abnormalities on the admission outcome and survival of palliative care cancer referrals

Journal of Palliative Medicine

Volumn 12, Issue 2, 2009, Pages 177-180

  Alsirafy, Samy A ^a,b   Sroor, Mahmoud Y ^a   Al Shahri, Mohammad Z ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ELECTROLYTE; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; ELECTROLYTE DISTURBANCE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERNATREMIA; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; PATIENT ADMISSION; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SAUDI ARABIA; SURVIVAL ANALYSIS; WATER-ELECTROLYTE BALANCE; YOUNG ADULT;

EID: 60049095618     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.0200     Document Type: Article

References (20)

1. Glare P, Christakis N: Predicting survival in patients with advanced disease. In: Doyle D, Hanks G, Cherny N, Calman K (eds): Oxford Textbook of Palliative Medicine. New York: Oxford University Press, 2004, pp. 29-42.
2. Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio A, Terzoli E, Luzzani M, De Marinis F, Caraceni A, Labianca R: Biological indices predictive of survival in 519 Italian terminally ill cancer patients: Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1997;13:1-9.
3. Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F,Roth S, Budach W, Franz M, Willers R: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 2007;25:3313-3320.
4. Alsirafy SA, Al-Shahri MZ, Hassan A, Hidayetullah M, Ghanem H: Pattern of electrolyte abnormalities among cancer patients referred to palliative care: A review of 750 patients. Prog Palliat Care 2007;15:182-186.
5. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S; Steering Committee of the European Association for Palliative Care: Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - A study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005;23:6240-6248.
6. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. 2006. http://ctep.cancer.gov (Last accessed July 19, 2008).
7. Kimura T, Kudoh S, Hirata K, Takifuji N, Negoro S, Yoshikawa J: Prognostic factors in elderly patients with unresectable non-small cell lung cancer. Anticancer Res 2001;21:1379-1383.
8. Osterlind K, Hansen HH, Dombernowsky P, Hansen M, Andersen PK: Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer. Cancer Res 1987; 47:2733-2736.
9. Penel N, Berthon C, Everard F, Neu JC, Clisant S, N'guyen M, Villet S, Fournier C, Lefebvre JL: Prognosis of hypercalcemia in aerodigestive tract cancers: Study of 136 recent cases. Oral Oncol 2005;41:884-889.
10. Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions: The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol 2008;3:457-466.
11. Tucci M, Mosca A, Lamanna G, Porpiglia F, Terzolo M, Vana F, Cracco C, Russo L, Gorzegno G, Tampellini M, Torta M, Reimondo G, Poggio M, Scarpa RM, Angeli A, Dogliotti L, Berruti A: Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. Prostate Cancer Prostatic Dis (in press).
12. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC: Prediction of life-expectancy in hospice patients: Identification of novel prognostic factors. Palliat Med 1993;7:199-204.
13. Palevsky PM, Bhagrath R, Greenberg A: Hypernatremia in hospitalized patients. Ann Internal Med 1996;124:197-203.
14. Longo WE, Virgo KS, Johnson FE, Oprian CA, Vernava AM, Wade TP, Phelan MA,Henderson WG, Daley J, Khuri SF: Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 2000;43:83-91.
15. Adrogue HJ, Madias NE: Hypernatremia. N Engl J Med 2000;342:1493-1499.
16. Fojo AT.: Oncologic emergencies, metabolic emergencies. In: Devita VT Jr, Hellman S, Rodenberg S (eds): Cancer, Priniciples and Practice of Oncology. Philadelphia: Lippincot Williams & Wilkins, 2005, pp. 2292-2300.
17. Onishi S, Yoshino S: Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006;45:207-210.
18. Schelling JR: Fatal hypermagnesemia. Clin Nephrol 2000;53:61-65.
19. Weisinger JR, Bellorin-Font E: Magnesium and phosphorus. Lancet 1998;352:391-396.
20. Escuela MP, Guerra M, Añón JM, Martínez- Vizcaíno V, Zapatero MD, García-Jalón A, Celaya S: Total and ionized serum magnesium in critically ill patients. Intensive Care Med 2005;31:151-156.